Press releases
- Nordic Nanovector board member resigns
- Nordic Nanovector ASA: Extraordinary General Meeting held
- Nordic Nanovector ASA - Notice of Extraordinary General Meeting on 3 January 2023
- Nordic Nanovector update following shareholder vote against proposed merger with APIM Therapeutics
- Nordic Nanovector Launches Dedicated Area on its Website in Norwegian for Information on the Proposed Merger with APIM Therapeutics
- Nordic Nanovector: Invitation to webcast regarding proposed merger with APIM Therapeutics
- Nordic Nanovector comment on Proposed Merger with APIM Therapeutics
- Nordic Nanovector ASA - Notice of Extraordinary General Meeting on 1 December 2022
- Nordic Nanovector and APIM Therapeutics Announce Merger Agreement
- Nordic Nanovector Highlights Novel Humanized Anti-CD37 Therapeutic Antibody Candidates for B-cell Malignancies or B-cell-driven Autoimmune Disorders at ASH Annual Meeting
More ▼
Key statistics
On Friday, Nordic Nanovector ASA (0R6Y:LSE) closed at 1.01, 9.97% above its 52-week low of 0.9175, set on Nov 29, 2022.
52-week range
Markit short selling activity
Open | 1.01 |
---|---|
High | -- |
Low | -- |
Bid | 0.959 |
Offer | 1.06 |
Previous close | 0.9945 |
Average volume | 0.00 |
---|---|
Shares outstanding | 116.04m |
Free float | 97.05m |
P/E (TTM) | -- |
Market cap | 116.04m NOK |
EPS (TTM) | -4.20 NOK |
Data delayed at least 20 minutes, as of Jan 06 2023 15:42 GMT.
More ▼